How dangerous is Barrett's metaplasia?;Barrett-metaplasie: Wie gefährlich ist sie wirklich?

Zeitschrift fur Gastroenterologie

Volumn 40, Issue SUPPL. 2, 2002, Pages 5-8

  Stolte, M ^a   Vieth, M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; BARRETT ESOPHAGUS; CANCER RISK; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSPLASIA; ENDOSCOPY; EROSION; ESOPHAGUS CARCINOMA; ESOPHAGUS ULCER; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; META ANALYSIS; MULTICENTER STUDY; POLYPECTOMY; PREVALENCE; PROSPECTIVE STUDY; PUBLICATION; REFLUX ESOPHAGITIS; RETROSPECTIVE STUDY; SCREENING; UNITED STATES;

EID: 0036941655     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-35907     Document Type: Conference Paper

References (29)

1. Rösch W, Blum AL. Volkskrankheit Sodbrennen. Vom "pathologischen Reflux" zur Refluxoesophagitis. Dtsch Ärztebl 1993; 90: C127-132
2. Atkinson M, Syiftikhar JPD, Robertson LS et al. The early diagnosis of oesophageal adenocarcinoma by endoscopic screening. Eur J Cancer Prev 1992; 1: 327-330
3. Cameron AJ, Lomboy CT, Pera M et al. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 1995; 109: 1541-1546
4. Hameetemann W, Tytgat GNJ, Houthoff HJ et al. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989; 96: 1249-1256
5. Polepalle S, Mc Callum RW. Barrett's esophagus: Current assessment and future perspectives. Gastroenterol Clin North Am 1990; 19: 733-744
6. Sampliner R, Mackel C, Fennerty MB et al. Prospective incidence of cancer in Barrett's esophagus. Gastroenterology 1991; 100: A153
7. Karras DJ, Michalos A. Importance of endoscopic surveillance in Barrett's esophagus. Gastroenterology 1991; 100: A95
8. Böhmer CJ, Hop WCJ, Meuwissen SGM et al. Carcinoma of Barrett's esophagus, do smoking and alcohol really matter? Gastroenterology 2000; 118: A459
9. Shaheen NJ, Crosby MA, Bozymski EM et al. Is there a publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 2000; 119: 333-338
10. Jankowski JA, Provenzale D, Moayyedi P. Esophageal adenocarcinoma arising from Barrett's metaplasia has regional variations in the West. Gastroenterology 2002; 122: 588-589
11. Jankowski JA, Harrison RE, Perry I et al. Barrett's metaplasia. Lancet 2000; 356: 2079-2085
12. Montgomery E, Bronner MP, Greenson JK et al. Are ulcers a marker for invasive carcinoma in Barrett's esophagus? Data from a diagnostic variability study with clinical follow-up. Am J Gastroenterol 2002; 97: 27-31
13. Weston AP, Badr AS, Hassanein RS. Prospective multivariante analysis of clinical, endoscopic and histologic factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma. Am J Gastroenterol 1999; 94: 3413-3419
14. Schnell, Sontag SJ, Chejfec G et al. Long-term nonsurgical management of Barrrett's esophagus with high-grade dysplasia. Gastroenterology 2001; 120: 1607-1619
15. Vieth M, Stolte M. Barrett's esophagus and neoplasia: Data from the Bayreuth Barrett's archive. Gastroenterology 2002; 122: 590
16. Buttar NS, Want KK, Sebo TJ. Extent of high grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma. Gastroenterology 2001; 120: 1630-1639
17. Robertson CS, Mayberry IF, Nicholson DA. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophgaus. Br J Surg 1988; 75: 760-763
18. Miros M, Kerlin P, Walker N. Only patients with dysplasia progress to andocarcinoma in Barrett's oesophagus. Gut 1991; 32: 1441-1446
19. Reid B, Levine D, Longton G. Predictors of progression to cancer in Barrett's esophagus: Baseline histology and flow cytometry identify low and high risk patient subsets. Am J Gastroenterology 2000; 95: 1669-1676
20. Inadomi JM, Sampliner R, Lagergren J et al. Cost-effectiveness of screening and surveillance of Barrett's esophagus: more targeted screening, less surveillance!. Gastroenterology 2002; 122: A287
21. Stolte M, Vieth M. Fondement histopathologique des modifications de la muqueuse oesophagienne. Ce que l'endoscopiste peut (et doit) voir. Acta Endoscopica 2001; 31: 125-129
22. Schulz H, Miehlke S, Antos D et al. Ablation of Barrett's epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole. Gastrointest Endosc 2000; 51: 659-663
23. Sampliner R and the Practice Parameters Committee of the American College of Gastroenterology. Practice Guidelines on the Diagnosis, Surveillance, and Therapy of Barrett's Esophagus. Am J Gastroenterol 1998; 93: 1028-1032
24. Ell C, May A, Gossner L. Endoscopic mucosal resection of early cancer and high grade dysplasia in Barrett's esophagus. Gastroenterology 2000; 118: 670-677
25. Sampliner RE and the Practice Parameters Committee of the American College of Gastroenteroloy. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002; 97: 1888-1895
26. Van Sandick JW, van Lanschot JJB, Tytgat GNJ et al. The impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and postoperative survival of Barrett's carcinoma. Gut 1998; 43: 216-222
27. Streitz JM Jr, Andrews CWJr, Ellis FH Jr. Endoscopic surveillance of Barrett's esophagus. Does it help? J Thorac Cardiovasc Surg 1993; 105: 383-388
28. Peters JH, Clark GWP, Ireland AP et al. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 1994; 108: 813-822
29. Corley DA, Levin TR, Habel LA et al. Surveillance and survival in Barrett's adenocarcinomas: A population-based study. Gastroenterology 2002; 122: 633-640